A robust and efficient protein biomarker development pipeline helps scientists overcome common challenges associated with ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...

Researchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including ...

Interleukin-6 could help physicians diagnose sepsis early in children and pregnant women, according to a real-world study presented at the ESCMID Global meeting 2025.“Traditional biomarkers have a lag ...

Explore how proteomics, AI and microsampling are advancing biomarker discovery. Learn how these innovations are shaping the ...

A study identifies beta-synuclein in blood as a potential early biomarker for Alzheimer’s disease. This protein’s levels rise ...

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful ...

Sponsored content brought to you by The advent of multiomic approaches has significantly improved early cancer detection by ...